 |
 |
 |
|||||||||||
|
TRAZAMINE™ is a convenience pack that Includes SentraPM™ and trazadone. In this dual management system, trazadone is administered as 50 mg at bedtime while Sentra PM™ is administered once daily at bedtime. Trazadone used alone, treats insomnia and is often used at a dose of 100 mg twice daily Sentra PM™is used to manage the nutritional deficiencies associated with insomnia and sleep latency insomnia. Trazamine™ is a dual management system that includes a pharmaceutical agent to treat insomnia and a Medical Food to manage the associated nutritional deficiency. In a clinical cross over study of patients with insomnia TRAZAMINE™ nutritional deficiency. In a clinical cross over study of patients with insomnia TRAZAMINE™ reduced sleep latency and increased duration of sleep when compared to trazadone used alone.
Trazadone is used alone or in combination with other medications for the treatment of sleep disorders and depression. Trazadone is also used to reduce the symptoms of agoraphobia, drug induced insomnia, essential tremor, and some pain syndromes. How does Trazadone work? This prescription drug helps to relieve depression by increasing the amount of a chemical called serotonin in brain centers. Sentra PM™: Why is this medication prescribed?Sentra PM™ is a Medical Food product that provides the amino acids that are precursors to the neurotransmitters that have been depleted due to certain disease states or as a result of certain drug side effects. This Medical Food stimulates the body to produce the neurotransmitters that induce sleep, promote restorative sleep, and reduce snoring. Patients with sleep disorders frequently experience a nutritional deficiency of tryptophan and choline. Patients with sleep disorders frequently show reduced blood levels of serotonin and 5-hydroxytryptophan. Choline deficiency has also been associated with sleep disorders, particularly those associated with sleep apnea syndromes. Sentra PM™ aids in the nutritional management of serotonin and acetylcholine production deficiencies in patients with sleep disorders and depression. NDC # 68405-8003-06 Insurance Reimbursement Code |
||||||||||
 |
|||||||||||
|
|||||||||||
 |
|||||||||||
Trazamine™
